Skip to content

Author

Elaine Lai-Han Leung

We have 3 of 20 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Leucine-derived isovaleric acid remodels the tumor microenvironment by degrading EIF3I.

Metabolic reprogramming and immune evasion are hallmarks of cancer. Although leucine is well known for regulating protein synthesis, its role in immunometabolic interactions within the tumor microenvironment (TME) remains unclear. In this study, we found that leucine supplementation significantly inhibited tumor growth...

Jia-Hui Xu, Zi-Ming Wang, Chun-Li Wei et al. · 0 citations
Review Open access Oct 2026

From Toxicity to Therapy: Probiotics and Novel Adsorbents in Aflatoxin Detoxification.

Aflatoxins (AFs), toxic secondary metabolites primarily produced by Aspergillus flavus and A. parasiticus, remain a serious global health challenge due to both acute and particularly chronic toxicity. Unlike acute toxicity, chronic low-dose exposure to AFs is insidious and cumulative, leading to long-term effects such...

Zi-Ying Huang, Chun Xie, Guang Yang et al. · 0 citations
Review Aug 2026

Biomarker-Driven Insights into Immune Checkpoint Inhibitor Therapy in Small-Cell Lung Cancer.

The pivotal roles of biomarkers in SCLC are highlighted, underscoring their contributions to treatment resistance across tumor-intrinsic mechanisms, immune landscape of the tumor microenvironment (TME) and systemic host factors.

Shu-Xing Wang, Xin-rui Zhao, Yue-Yue Zeng et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.